SCHEMBL25083274

SCHEMBL25083274

CCNCC(=O)NCCSCCC(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
CNR1 P21554 1/20 0.35
ALDH1A1 P00352 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
GBA1 P04062 2/20 0.32
TERT O14746 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
CYP2C19 P33261 1/20 0.31
LMNA P02545 1/20 0.31
PKM P14618 1/20 0.31
MAPK1 P28482 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
KMT2A Q03164 1/20 0.30
NAMPT P43490 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22338190 0.82 TSHR (0.41) TSHRCNR1ALDH1A1GAAMAPT
SCHEMBL16405258 0.80 GBA1 (0.47) TSHRCNR1ALDH1A1GBA1SMN1; SMN2
SCHEMBL22338220 0.80 TSHR (0.45) TSHRALDH1A1GAAGBA1SMN1; SMN2
SCHEMBL22338189 0.78 TSHR (0.38) TSHRCNR1ALDH1A1GAAKMT2A
SCHEMBL8975622 0.77 KMT2A (0.37) TSHRALDH1A1GAATERTPOLB
SCHEMBL24330012 0.77 MEN1 (0.44) CNR1ALDH1A1SMN1; SMN2TP53MAPK1
SCHEMBL18602384 0.70 MCL1 (0.54) TSHRCNR1ALDH1A1GAATERT
SCHEMBL13061925 0.70 GAA (0.39) ALDH1A1GAAALOX15SMN1; SMN2L3MBTL1
SCHEMBL25083177 0.69 TSHR (0.45) TSHRALDH1A1GBA1SMN1; SMN2TP53
SCHEMBL2019891 0.69 CNR1 (0.42) CNR1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230063768-A1 IMMUNOPHILIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230063768-A1 IMMUNOPHILIN BINDING AGENTS AND USES THEREOF PMP22, MAG, FABP7 TSHR 3931/4885CNR1 1886/4885ALDH1A1 2795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.